Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Hindsight>Brokers' Latest TPs/ Opinions on WUXI APPTEC After Quarterly Results
Recommend 6 Positive 2 Negative 0 |
||||
|
||||
|
Broker│ Rating│ Target Price (HKD) Nomura│Buy│157.07 Morgan Stanley│Overweight│155 JPMorgan│150 Goldman Sachs│ Buy (Conviction List Buy)│149.7 CLSA│ Conviction Outperform│149.3 Broker | Opinion Nomura | 1Q26 results were strong, an outstanding quarterly results Morgan Stanley | Share price is expected to rise over the next 30 days on higher earnings forecasts and results guidance JPMorgan | 1Q25 results beat expectations across the board, with margins widening Goldman Sachs | Improved operational efficiency drove 1Q26 revenue and earnings well above forecasts; Strong profitability maintained despite foreign exchange headwinds CLSA | 1Q26 results beat estimations and order intake remained solid, further enhancing visibility into future results Auto-translated by AI This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
